Gainesville, FL, United States of America

Stanislav Igorevich Svetlov

This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: University of Florida Research Foundation Inc., Banyan Biomarkers, Inc., Banyan Biomakers. Active years: 2009-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stanislav Igorevich Svetlov. Retrieved from https://idiyas.com/inventor/stanislav-igorevich-svetlov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 42.9


 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Alachua, FL (US) (2017 - 2020)
  • Gainesville, FL (US) (2009 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment: The Contributions of Stanislav Igorevich Svetlov

Introduction

Stanislav Igorevich Svetlov is a notable inventor based in Gainesville, Florida, with a focus on developing innovative treatments for central nervous system tumors and bacterial infections. He holds seven patents that showcase his contributions to the fields of medicine and biochemistry.

Latest Patents

Among Svetlov's most recent patents are two significant inventions aimed at treating complex health issues. The first patent, titled "Compositions and methods for the treatment of central nervous system tumors," involves compounds and pharmaceutical compositions capable of treating brain cancer. These include amphiphilic fatty acid/alcohol ethers (AIPs) that combine endocannabinoid and FABP motifs with beta-adrenoreceptor antagonist motifs. This invention details methods to inhibit the growth of brain cancer cells and offers strategies for treating both primary and metastatic brain cancer while preventing regrowth after conventional therapies such as radiation and chemotherapy.

The second patent focuses on "Compositions and methods relating to argininosuccinate synthetase," providing processes and compositions for the therapeutic treatment of pathogenic Gram-negative bacterial infections. By administering argininosuccinate synthetase or its PEGylated form, this invention aims to inactivate endotoxins, thereby reducing the risk of bacterial sepsis and improving patient outcomes.

Career Highlights

Stanislav has contributed significantly to the fields of research and biotech through his positions at renowned organizations. He has worked with the University of Florida Research Foundation and Banyan Biomarkers, Inc., where his innovative work has paved the way for advancements in medical treatments.

Collaborations

Throughout his career, Svetlov has collaborated with distinguished colleagues, including Ronald L. Hayes and Ka-Wang (Kevin) Wang. These partnerships have furthered his research and enhanced the impact of his inventions in the medical community.

Conclusion

Stanislav Igorevich Svetlov’s work exemplifies the intersection of innovation and healthcare. His patents not only contribute to scientific knowledge but also provide practical applications that hold the potential to save lives. Through his ongoing efforts, Svetlov continues to pave the way for groundbreaking treatments in the fight against severe health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…